AppliedVR launches RelieVRx® for workers’ compensation patients, payers and physicians
22 May 2024 - 8:01PM
Business Wire
Non-pharmacological treatment uses immersive
virtual reality to deliver a new standard of care for injured
workers suffering from chronic lower back pain (CLBP).
AppliedVR, a pioneer in immersive therapeutics advancing a novel
approach to medicine, has launched its flagship RelieVRx®
prescription therapeutic into workers’ compensation. The RelieVRx
device is the first comprehensive, immersive adjunctive virtual
reality treatment for chronic lower back pain to ever be
FDA-authorized.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240522897398/en/
AppliedVR launches RelieVRx for workers'
compensation. The first FDA-authorized virtual reality prescription
therapeutic for chronic lower back pain, RelieVRx provides a fully
immersive VR experience to help injured workers learn skills to
reduce & manage their CLBP. Extensive research shows the
home-based, self-administered program produces clinically
meaningful reductions in both pain intensity and pain interference
with sleep and activities. Developed by pain specialists led by
Stanford's Beth Darnall, PhD, the program incorporates validated
principles of cognitive behavioral therapy, biofeedback and
emotional regulation. See https://www.relievrx.com/workers-comp.
(Photo: Business Wire)
The RelieVRx device provides a fully immersive VR experience
that helps workers’ compensation patients learn skills that help
them reduce and manage CLBP. It is a cost-effective,
non-pharmacologic adjunctive pain therapy that has been clinically
demonstrated to reduce pain intensity and interference.
“The RelieVRx program is a safe and effective alternative to
common treatment modalities without any of the risks that opioids
and surgeries carry,” said AppliedVR’s Co-Founder and President
Josh Sackman. “We believe this program will receive broad
acceptance in the workers’ comp community.”
The RelieVRx program incorporates scientifically developed and
validated principles of cognitive behavioral therapy, biofeedback,
and emotional regulation to teach people how to manage and relieve
their pain. A team of clinicians, pain specialists and
psychologists led by Stanford University School of Medicine
Professor Beth Darnall, PhD, developed the therapeutic program used
by RelieVRx.
From the comfort of their homes, injured workers follow a series
of 56 chapters averaging approximately six minutes each. Each
session builds upon the last to induce neuroplasticity, which helps
to regulate the neural regions of the brain that are associated
with pain.
AppliedVR has conducted extensive clinical research evaluating
the RelieVRx program’s efficacy, including a large study with more
than 1,000 participants that recently published in the Mayo
Clinical Proceedings: Digital Health. Studies show that the device
produces clinically meaningful reductions in both pain intensity
and its interference with activities, sleep, mood, and stress both
at end of treatment and 24 months post treatment.
In 2021, the RelieVRx program became the first and only
FDA-authorized VR therapeutic for CLBP, and two years later
AppliedVR became the first virtual reality provider to receive a
unique Healthcare Common Procedure Coding System (HCPCS) Level II
code from the Centers for Medicare and Medicaid Services for
RelieVRx. Additionally, the RelieVRx program has been added to the
Federal Supply Schedule and has been used by the Veterans Health
Administration nationwide since early 2023.
To learn more about the workers’ compensation program, please
see Workers Comp | RelieVRx.
About AppliedVR
Based in Van Nuys, California, AppliedVR is a pioneer in
immersive therapeutics (ITx), a new category of medicine that
treats intractable health conditions. Its flagship RelieVRx program
is the first and only VR-based prescription therapeutic to receive
Breakthrough Device and De Novo authorization by the FDA for CLBP.
AppliedVR's wellness programs have been trusted by more than 200
leading health systems and thousands of healthcare professionals
globally, used by more than 60,000 patients. For more information,
visit https://www.appliedvr.io/.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240522897398/en/
Helen King Patterson, King Knight Communications, 813-690-4787,
helen@kingknight.com